In 2022
(2025, August 12)
Levels of PYY are body-weight dependent, with normal weight subjects presenting with higher levels of plasma PYY than obese humans, and elevations in PYY have also been seen after weight loss, especially in combination with exercise (75)
Screening for eating disorders or mental health conditions is highly recommended before starting a GLP-1
Reduced appetite = reduced intake = increased risk of missing key nutrients like: Protein Iron, calcium, magnesium, zinc, potassium, choline, folate
To be eligible for the plan, members must: Be enrolled in a standalone prescription drug plan (PDP), like Part D, or a Medicare Advantage (MA) plan Use GLP-1 medications to treat excess body weight and maintain weight loss Meet all clinical criteria Clinical criteria for Medicare GLP-1 Bridge program To qualify clinically, a health care provider must submit a prior authorization stating the medication is prescribed to reduce excess body weight and maintain weight reduction. The medication must also be used alongside current and ongoing lifestyle modifications, including a nutrition plan and consistent physical activity